News & Publications

2014 Corporate Reports

  • 5.6.2013

WilmerHale’s annual IPO, Venture Capital and M&A Reports provide comprehensive statistics and analysis that are hard to find elsewhere.

Our 2014 IPO Report a detailed analysis of, and outlook for, the IPO market. The report features regional breakdowns; useful IPO market metrics; an update on the pros, cons and recent rates of adoption of various elements of relief available to emerging growth companies; and a look at the expanded role CEOs now must play in the IPO process. We review important considerations around the inclusion of “flash results” in IPO ; present a primer on the characteristics of venture capital–backed and private equity–backed IPOs; and provide an overview of “cross-border” IPOs by foreign companies in the United States.

The 2014 Venture Capital Report an in-depth analysis of, and outlook for, the US and European venture capital markets. The report features industry and regional breakdowns, an analysis of trends in venture capital financing and VC-backed company M&A deal terms, and a look at important considerations for in light of provisions that loosen restrictions around general solicitation and .

Our 2014 M&A Report contains a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions, an update on takeover defenses, and insights into CFIUS and FCPA considerations in M&A transactions. We also look at financial statement requirements in mergers and acquisitions, and survey key terms in sales of VC-backed companies.

Each report also includes a center showcasing prominent recent transactions in each area and company counsel rankings from independent sources showing WilmerHale’s preeminence as counsel in IPOs, VC financings and sales of VC-backed companies.

To request a hard copy of any of the reports, contact the WilmerHale Marketing Department at [email protected] or call +1 617 526 5600.

See other News & Publications related to:

See related industries:

Life Sciences , Technology